Homre Ltd shareholders approve ₹12.49 crore warrant issue at AGM
- Shareholders approved a preferential issue of 5,41,12,552 fully convertible warrants at ₹2.31 each, aggregating to ₹12.49 crore
- The HOMRE Employees Stock Option Plan 2026 was approved, allowing grants of up to 3 crore stock options
- Several director appointments were regularised, including Sandeep Dewan as Managing Director and Shetal Jain as Chairperson
- M/s. Datt Ganesh & Associates was appointed as Secretarial Auditor for FY27
- The 36th AGM was held via video conferencing on September 24, 2026, with 66 members in attendance

*this image is generated using AI for illustrative purposes only.
Homre Limited shareholders approved a preferential issue of 5,41,12,552 fully convertible warrants at an issue price of ₹2.31 per warrant during its 36th Annual General Meeting held on September 24, 2026. This transaction aggregates to ₹12,49,99,997, marking a significant capital infusion for the company formerly known as Triton Corp Limited.
The meeting, conducted via Video Conferencing and Other Audio Visual Means, commenced at 1:00 pm and concluded at 1:42 pm. The proceedings included the adoption of the audited financial statements for the financial year ended March 31, 2026, alongside the reports of the Board of Directors, Statutory Auditors, and Secretarial Auditors.
Key resolutions passed
The special business items approved by shareholders focused on capital structuring and governance regularisation. The most material financial decision involved the issuance of warrants and the approval of a new employee stock option plan.
| Resolution Item | Details | Amount/Quantity |
|---|---|---|
| Preferential Issue | Fully Convertible Warrants | 5,41,12,552 warrants |
| Issue Price | Per warrant conversion basis | ₹2.31 |
| Total Aggregation | Gross proceeds from warrants | ₹12,49,99,997 |
| ESOP Scheme | HOMRE Employees Stock Option Plan 2026 | Up to 3,00,00,000 options |
The HOMRE ESOP 2026 allows for the grant of up to three crore stock options to eligible employees. Each option entitles the holder to one equity share with a face value of ₹1, subject to the scheme's terms.
Governance and board changes
Shareholders voted to regularise several director appointments and designations to align with regulatory requirements. Mrs. Shetal Jain was regularised as Chairperson and Non-Executive Director. Mr. Sandeep Dewan’s appointment as Managing Director was also regularised.
Additionally, the meeting approved the change in designation of Dr. Surendra Pal Sharma from Non-Executive Director to Executive Director. The appointments of independent directors, including Mr. Rohit Inder Himatsingani, Dr. Abhishek Bhagwat Bharad, Mrs. Supriya Mahesh Kadam, Mr. Ashok Chopra, and Mrs. Puneeta K. Sharma, were regularised. The meeting also noted the re-appointment of Mrs. Khushboo Rastogi, who retired by rotation.
Auditor appointment
The company appointed M/s. Datt Ganesh & Associates, Company Secretaries, as the Secretarial Auditor for the financial year 2026-27. The remuneration for this engagement will be mutually agreed upon between the Board and the auditor.
Meeting proceedings and voting
A total of 66 members, including five promoter shareholders, attended the meeting. The e-voting process, facilitated by National Securities Depository Limited (NSDL), commenced on September 21, 2026, and concluded on September 23, 2026, with additional voting rights extended for 15 minutes post-meeting. Mr. Ajay Kumar Choudhry of M/s A.K. Choudhary & Associates served as the scrutinizer. The results were subsequently disseminated to the exchanges.
Historical Stock Returns for HOMRE
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +9.60% | +16.87% | -6.73% | +43.70% | +59.02% | 0.0% |
How will the ₹12.5 crore capital infusion from the preferential issue specifically impact Homre Limited's operational expansion or debt reduction strategy in the upcoming fiscal year?
What are the potential dilution effects on existing shareholders' equity once the 5.41 crore fully convertible warrants are exercised at the ₹2.31 price point?
Given the recent rebranding from Triton Corp to Homre Limited, how does the new ESOP scheme align with the company's revised long-term business objectives and talent retention goals?

































